{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:45:32Z","timestamp":1786589132989,"version":"build-2736575974"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1681\/asn.2010060594","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T23:13:15Z","timestamp":1298070795000},"page":"664-672","source":"Crossref","is-referenced-by-count":25,"title":["Cyclooxygenase 2 Promotes Parathyroid Hyperplasia in ESRD"],"prefix":"10.1681","volume":"22","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Ming","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20230423","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ki.1997.297","article-title":"The hyperparathyroidism of chronic renal failure: A disorder of growth","volume":"52","author":"Parfitt","year":"1997","journal-title":"Kidney Int"},{"key":"R2-14-20230423","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndt\/10.supp3.13","article-title":"Renal osteodystrophy: Pathogenesis and management","volume":"10","author":"Gonzalez","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"R3-14-20230423","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"R4-14-20230423","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000188261","article-title":"Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients","volume":"68","author":"Fukagawa","year":"1994","journal-title":"Nephron"},{"key":"R5-14-20230423","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0272-6386(00)70199-5","article-title":"Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism","volume":"35","author":"Katoh","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R6-14-20230423","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.1997.1420959.x","article-title":"The basal rate of cell proliferation in normal human parathyroid tissue: Implications for the pathogenesis of hyperparathyroidism","volume":"46","author":"Wang","year":"1997","journal-title":"Clin Endocrinol (Oxf"},{"key":"R7-14-20230423","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1172\/JCI118224","article-title":"Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D","volume":"96","author":"Naveh-Many","year":"1995","journal-title":"J Clin Invest"},{"key":"R8-14-20230423","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","article-title":"Mechanisms of secondary hyperparathyroidism","volume":"283","author":"Silver","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"R9-14-20230423","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI117890","article-title":"Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia","volume":"95","author":"Arnold","year":"1995","journal-title":"J Clin Invest"},{"key":"R10-14-20230423","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s002689900113","article-title":"Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism","volume":"20","author":"Tominaga","year":"1996","journal-title":"World J Surg"},{"key":"R11-14-20230423","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1523-1755.1999.00396.x","article-title":"Expression of PRAD1\/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma","volume":"55","author":"Tominaga","year":"1999","journal-title":"Kidney Int"},{"key":"R12-14-20230423","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"R13-14-20230423","first-page":"1598","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-14-20230423","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","article-title":"Development and progression of secondary hyperparathyroidism in chronic kidney disease: Lessons from molecular genetics","volume":"74","author":"Goodman","year":"2008","journal-title":"Kidney Int"},{"key":"R15-14-20230423","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1523-1755.2002.kid585.x","article-title":"Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism","volume":"62","author":"Tokumoto","year":"2002","journal-title":"Kidney Int"},{"key":"R16-14-20230423","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1046\/j.1523-1755.2001.00042.x","article-title":"p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium","volume":"60","author":"Cozzolino","year":"2001","journal-title":"Kidney Int"},{"key":"R17-14-20230423","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1681\/ASN.2007040406","article-title":"EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease","volume":"19","author":"Arcidiacono","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R18-14-20230423","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jsbmb.2004.03.061","article-title":"1,25-Dihydroxyvitamin D downregulation of TGFalpha\/EGFR expression and growth signaling: A mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure","volume":"89-90","author":"Dusso","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R19-14-20230423","doi-asserted-by":"crossref","first-page":"33157","DOI":"10.1074\/jbc.271.52.33157","article-title":"Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2","volume":"271","author":"Smith","year":"1996","journal-title":"J Biol Chem"},{"key":"R20-14-20230423","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncponc0140","article-title":"Mechanisms of disease: Inflammatory mediators and cancer prevention","volume":"2","author":"Mann","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"R21-14-20230423","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1016\/S0021-9258(18)98774-0","article-title":"TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase\/cyclooxygenase homologue","volume":"266","author":"Kujubu","year":"1991","journal-title":"J Biol Chem"},{"key":"R22-14-20230423","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1470-2045(01)00488-0","article-title":"Cyclo-oxygenase 2: A pharmacological target for the prevention of cancer","volume":"2","author":"Dannenberg","year":"2001","journal-title":"Lancet Oncol"},{"key":"R23-14-20230423","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10787-009-8049-8","article-title":"Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung","volume":"17","author":"Harris","year":"2009","journal-title":"Inflammopharmacology"},{"key":"R24-14-20230423","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0090-6980(85)90149-2","article-title":"Production of prostaglandins by dispersed cells and fragments from bovine parathyroid glands","volume":"29","author":"Brown","year":"1985","journal-title":"Prostaglandins"},{"key":"R25-14-20230423","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/EP:15:1:29","article-title":"Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland","volume":"15","author":"Bell","year":"2004","journal-title":"Endocr Pathol"},{"key":"R26-14-20230423","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/jcem-51-1-20","article-title":"Prostaglandin-mediated stimulation of adenosine 3\u2032,5\u2032-monophosphate accumulation and parathyroid hormone release in dispersed human parathyroid cells","volume":"51","author":"Gardner","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-14-20230423","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/endo-103-2-577","article-title":"Prostaglandin E2 stimulation of adenosine 3\u2032,5\u2032-monophosphate accumulation and parathyroid hormone release in dispersed bovine parathyroid cells","volume":"103","author":"Gardner","year":"1978","journal-title":"Endocrinology"},{"key":"R28-14-20230423","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0046-8177(85)80248-3","article-title":"Pathologic study of parathyroid glands in tertiary hyperparathyroidism","volume":"16","author":"Krause","year":"1985","journal-title":"Hum Pathol"},{"key":"R29-14-20230423","first-page":"2681","article-title":"Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism","volume":"82","author":"Yamaguchi","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-14-20230423","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF00353781","article-title":"Expression of proliferating cell nuclear antigens in parathyroid glands of renal hyperparathyroidism","volume":"18","author":"Ohta","year":"1994","journal-title":"World J Surg"},{"key":"R31-14-20230423","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mc.20326","article-title":"The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis","volume":"46","author":"Muller-Decker","year":"2007","journal-title":"Mol Carcinog"},{"key":"R32-14-20230423","first-page":"1339","article-title":"Phospholipase-A2 action and arachidonic acid metabolism in calcium-mediated parathyroid hormone secretion","volume":"130","author":"Bourdeau","year":"1992","journal-title":"Endocrinology"},{"key":"R33-14-20230423","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/endo.135.3.8070353","article-title":"Effects of lipoxygenase products of arachidonate metabolism on parathyroid hormone secretion","volume":"135","author":"Bourdeau","year":"1994","journal-title":"Endocrinology"},{"key":"R34-14-20230423","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1681\/ASN.V1191712","article-title":"Effect of high extracellular phosphate concentration on arachidonic acid production by parathyroid tissue in vitro","volume":"11","author":"Almaden","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R36-14-20230423","doi-asserted-by":"crossref","first-page":"F1197","DOI":"10.1152\/ajprenal.00529.2009","article-title":"Upregulation of parathyroid VDR expression by extracellular calcium is mediated by ERK1\/2-MAPK signaling pathway","volume":"298","author":"Canadillas","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R37-14-20230423","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0272-6386(96)90473-4","article-title":"Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure","volume":"28","author":"Denda","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R38-14-20230423","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijrobp.2006.09.055","article-title":"Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: Inhibition of tumor angiogenesis with extensive tumor necrosis","volume":"67","author":"Kang","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R39-14-20230423","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/mt.2009.118","article-title":"Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancer","volume":"17","author":"Chang","year":"2009","journal-title":"Mol Ther"},{"key":"R40-14-20230423","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1096\/fj.01-0299fje","article-title":"COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib","volume":"15","author":"Grosch","year":"2001","journal-title":"FASEB J"},{"key":"R41-14-20230423","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.eururo.2008.01.013","article-title":"Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma","volume":"54","author":"Dovedi","year":"2008","journal-title":"Eur Urol"},{"key":"R42-14-20230423","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/carcin\/bgh340","article-title":"A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats","volume":"26","author":"Oyama","year":"2005","journal-title":"Carcinogenesis"},{"key":"R43-14-20230423","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1046\/j.1523-1755.2000.00093.x","article-title":"A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats","volume":"57","author":"Wang","year":"2000","journal-title":"Kidney Int"},{"key":"R44-14-20230423","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1046\/j.1523-1755.2003.00319.x","article-title":"Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney","volume":"64","author":"Fujihara","year":"2003","journal-title":"Kidney Int"},{"key":"R45-14-20230423","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/01.HYP.34.4.848","article-title":"Effect of cyclooxygenase-2 inhibition on renal function after renal ablation","volume":"34","author":"Sanchez","year":"1999","journal-title":"Hypertension"},{"key":"R46-14-20230423","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.physiol.70.113006.100614","article-title":"Physiological regulation of prostaglandins in the kidney","volume":"70","author":"Hao","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"R47-14-20230423","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.med.53.082901.103952","article-title":"Cyclooxygenase-2: A therapeutic target","volume":"53","author":"Turini","year":"2002","journal-title":"Annu Rev Med"},{"key":"R48-14-20230423","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1146\/annurev.pharmtox.41.1.661","article-title":"Prostanoid receptors: Subtypes and signaling","volume":"41","author":"Breyer","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R49-14-20230423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/endo-104-1-1","article-title":"Prostaglandin F2alpha inhibits 3\u2032,3\u2032-adenosine monophosphate accumulation and parathyroid hormone release from dispersed bovine parathyroid cells","volume":"104","author":"Gardner","year":"1979","journal-title":"Endocrinology"},{"key":"R51-14-20230423","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1096\/fj.09-141341","article-title":"PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis","volume":"24","author":"Tian","year":"2010","journal-title":"FASEB J"},{"key":"R52-14-20230423","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1158\/1078-0432.CCR-04-0315","article-title":"Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells","volume":"10","author":"Spinella","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R53-14-20230423","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1073\/pnas.88.10.4235","article-title":"Endothelin as an autocrine factor in the regulation of parathyroid cells","volume":"88","author":"Fujii","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R54-14-20230423","first-page":"99","article-title":"Regulation of parathyroid cell gene expression in experimental uremia","volume":"1","author":"Shvil","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"R55-14-20230423","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1097\/01.ASN.0000141016.20133.33","article-title":"Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency","volume":"15","author":"Mizobuchi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R56-14-20230423","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1046\/j.1523-1755.2002.00265.x","article-title":"Hyperplasia of the parathyroid gland without secondary hyperparathyroidism","volume":"61","author":"Takahashi","year":"2002","journal-title":"Kidney Int"},{"key":"R57-14-20230423","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/ndt\/16.9.1870","article-title":"Sevelamer hydrochloride (Renagel), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency","volume":"16","author":"Nagano","year":"2001","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201104000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:32:38Z","timestamp":1786131158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201104000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2010060594","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}